Carfilzomib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Carfilzomib
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Carfilzomib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 16 USDMF, 6 EU WC, 5 KDMF, 11 NDC API, 24 Listed Suppliers, $ API Reference Price

36 API Suppliers
16 USDMF
6 EU WC
5 KDMF
11 NDC API
24 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

55 FDF Dossiers, 13 FDA Orange Book, 7 Europe, 3 Canada, 18 Australia, 1 South Africa, 13 Listed Dossiers

55 FDF Dossiers
13 FDA Orange Book
7 Europe
3 Canada
18 Australia
1 South Africa
13 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Gangwal Chemicals

1 Gangwal Chemicals

EXCIPIENTS BY APPLICATIONS

1 Parenteral, 1 Solubilizers, 1 Taste Masking, 1 Emulsifying Agents, 1 Thickeners and Stabilizers, 1 Dry Powder Inhalation

1 Parenteral
1 Solubilizers
1 Taste Masking
1 Emulsifying Agents
1 Thickeners and Stabilizers
1 Dry Powder Inhalation

DIGITAL CONTENT

122 NEWS #PharmaBuzz

122 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Finished Drug Prices, 19 Annual Reports

1 US Medicaid Prescriptions
6 Finished Drug Prices
19 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

4 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

57 US Patents, 6 Health Canada Patents

57 US Patents
6 Health Canada Patents

$ API Ref.Price (USD/KG) : 363,511 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Amgen Canada Inc.

filter Patent Reset all filters

6 All

01 32589765

02 32589921

filter Product Reset all filters

6 All

01 6CARFILZOMIB

filter Dosage Reset all filters

6 All

01 6POWDER FOR SOLUTION

filter Exp Date Reset all filters

6 All

01 32025-08-08

02 32025-12-07

Product Main Page

01

Amgen Canada Inc.

Carfilzomib

BioAsia

Not Confirmed

Amgen Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Carfilzomib

Brand Name : KYPROLIS

Patent Number : 2589765

Filing Date : 2005-08-08

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Amgen Canada Inc.

Carfilzomib

BioAsia

Not Confirmed

Amgen Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Carfilzomib

Brand Name : KYPROLIS

Patent Number : 2589921

Filing Date : 2005-12-07

Strength per Unit : 60 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Amgen Canada Inc.

Carfilzomib

BioAsia

Not Confirmed

Amgen Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Carfilzomib

Brand Name : KYPROLIS

Patent Number : 2589765

Filing Date : 2005-08-08

Strength per Unit : 10 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Amgen Canada Inc.

Carfilzomib

BioAsia

Not Confirmed

Amgen Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Carfilzomib

Brand Name : KYPROLIS

Patent Number : 2589921

Filing Date : 2005-12-07

Strength per Unit : 10 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Amgen Canada Inc.

Carfilzomib

BioAsia

Not Confirmed

Amgen Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Carfilzomib

Brand Name : KYPROLIS

Patent Number : 2589921

Filing Date : 2005-12-07

Strength per Unit : 30 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-12-07

Date Granted : 2016-01-26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Amgen Canada Inc.

Carfilzomib

BioAsia

Not Confirmed

Amgen Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Carfilzomib

Brand Name : KYPROLIS

Patent Number : 2589765

Filing Date : 2005-08-08

Strength per Unit : 30 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-08-08

Date Granted : 2015-06-30

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!